Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin's lymphoma: A case study;Multicenterevaluierung unterschiedlicher Zielvolumenkonzepte für pädiatrische Hodgkin-Erkrankungen: Eine Fallstudie

Strahlentherapie und Onkologie

Volumn 188, Issue 11, 2012, Pages 1025-1030

  Lutgendorf Caucig C ^a   Fotina, I ^a   Gallop Evans, E ^b   Claude, L ^c   Lindh, J ^d   Pelz, T ^e   Knausl B ^a   Georg, D ^a   Potter R ^a   Dieckmann, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b VELINDRE CANCER CENTRE   (United Kingdom)

^c CENTRE LÉON BÉRARD   (France)

^d UMEÅ UNIVERSITY   (Sweden)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Interobserver variability; Involved node radiotherapy; Involved node level radiotherapy; Pediatric Hodgkin's lymphoma; Target volume delineation

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CHILDHOOD CANCER; DISPERSION; FEASIBILITY STUDY; FEMALE; HODGKIN DISEASE; HUMAN; INVOLVED NODE; INVOLVED NODE LEVEL; LYMPH NODE METASTASIS; MALE; MEDIASTINUM; MULTICENTER STUDY; NECK; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; REPRODUCIBILITY; TUMOR VOLUME; VOLUMETRY;

ADOLESCENT; FEASIBILITY STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; OBSERVER VARIATION; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 84867938517     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0182-4     Document Type: Article

References (32)

1. Bowden P, Fisher R, Mac Manus M et al (2002) Measurement of lung tumor volumes using three-dimensional computer planning software. Int J Radiat Oncol Biol Phys 53:566-573
2. Campbell BA, Voss N, Pickles T et al (2008) Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size. J Clin Oncol 26:5170-5174
3. Chapet O, Kong FM, Quint LE et al (2005) CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63:170-178
4. Dörffel W, Lüders H, Rühl U et al (2003) Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook. Klin Padiatr 215(3):139-145
5. Eich HT, Müller RP, Engenhart-Cabillic R et al (2008) Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 184:406-410
6. Fodor A, Fiorino C, Dell'Oca I et al (2011) PET-guided dose escalation tomotherapy in malignant pleural mesothelioma. Strahlenther Onkol 187(11):736-743
7. Fotina I, Lütgendorf-Caucig C, Stock M et al (2012) Critical discussion of evaluation parameters for inter observer variability in target definition for radiation therapy. Strahlenther Onkol 188(2):160-167
8. Genovesi D, Cèfaro GA, Vinciguerra A et al (2011) Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience. Strahlenther Onkol 187:357-366
9. Girinsky T, Specht L, Ghalibafian M et al (2008) The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 88:202-210
10. Girinsky T, Maazen R van der, Specht L et al (2006) Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79:270-277
11. Grégoire V, Levendag P, Ang KK et al (2003) CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227-236
12. International Commission of Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Report 50, ICRU, Bethesda, MD, 1993
13. International Commission of Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU report 50). ICRU Report 62, ICRU, Bethesda, MD, 1999
14. Körholz D, Claviez A, Hasenclever D et al (2004) The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. Klin Padiatr 216:150-156
15. Körholz D, Wallace H, Landman-Parker J (2006) EuroNet-Paediatric Hodgkin's Lymphoma Group, First international Inter-Group Study for classical Hodgkin's Lymphoma in Children and Adolescents, Radiotherapy Manual; Version 2006-8-11
16. Kouwenhoven E, Giezen M, Struikmans H (2009) Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol 54:2863-2873
17. Kriz J, Bangard C, Haverkamp U et al (2012) Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review: comparison of the results between two study generations of the German Hodgkin Study Group. Strahlenther Onkol (Epub ahead of print)
18. Lammering G, De Ruysscher D, Baardwijk A van et al (2010) The use of FDG-PET to target tumors by radiotherapy. Strahlenther Onkol 186:471-481
19. Lütgendorf-Caucig C, Fotina I, Stock M et al (2011) Feasibility of CBCT based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. Radiother Oncol 98:154-161
20. Mauz-Körholz C, Hasenclever D, Dörffel W et al (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol 28:3680-3686
21. Metwally H, Courbon F, David I et al (2011) Coregistration of prechemotherapy PET-CT for planning pediatric hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition. Int J Radiat Oncol Biol Phys 80:793-799
22. Müller RP, Eich HT (2005) The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel. Strahlenther Onkol 181:557-566
23. Pötter R (1999) Paediatric Hodgkin's disease. Eur J Cancer 10:1466-1474
24. Pötter R, Dieckmann K, Hofmann U et al (1995) Individualisation of radiation fields based on modern sectional imaging within combination treatment of pediatric Hodgkin's Disease (HD): evaluation of 386 patients from the German-Austrian multicentre trial (HD-90). Int J Radiat Oncol Biol Phys 13(Suppl 1):178
25. Senan S, Piet A, Lagerwaard F (2007) Involved-node radiotherapy to the mediastinum. Radiother Oncol 82:108-109 (author reply 109-110)
26. Roth SL, Dühmke E, Kirschner H et al (1990) Radiotherapeutic quality assurance in the Hodgkin's disease study HD4 supported by the BMFT (Bundesministerium für Forschung und Technologie). Strahlenther Onkol 166:584-587
27. Schellong G, Pötter R, Brämswig J et al (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 17:3736-3744
28. Tyng CJ, Chojniak R, Pinto PN et al (2009) Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists. Radiat Oncol 4:28
29. Stroom JC, Heijmen BJ (2002) Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiother Oncol 64:75-83
30. Weiss E, Hess CF (2003) The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences. Strahlenther Onkol 179:21-30
31. Welte B, Suhr P, Bottke D et al (2010) Second malignancies in high - dose areas of previous tumor radiotherapy. Strahlenther Onkol 186:174-179
32. Wiegner EA, Donaldson SS (2011) Controversies in radiotherapy for pediatric Hodgkin's lymphoma. Expert Rev Anticancer Ther 11:1357-1366